Modine Manufacturing Company (MOD) 11.90

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Modine Manufacturing Company (MOD) 11.90 $MOD

Philadelphia Next Stop For Modine Innovation Tour
PR Newswire - Wed Sep 07, 4:06PM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, is going to be in Bensalem, Philadelphia, just northeast of Philadelphia, on Monday, September 19 at Parx Racing, from 8:30 a.m. to 4:30 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Modine Announces Agreement to Acquire Luvata Heat Transfer Solutions
PR Newswire - Tue Sep 06, 5:45PM CDT
Modine Manufacturing Company (NYSE: MOD), a diversified global leader in thermal management technology and solutions, today announced that it has entered into a definitive agreement to acquire Luvata Heat Transfer Solutions (HTS) for a total consideration of approximately $422 million, to be financed through a combination of cash, debt, and $25 million of Modine common stock. Modine expects the transaction to close within calendar year 2016, subject to customary closing conditions, including regulatory review.
MOD: 11.90 (+0.48)

Modine Innovation Tour Heads to Warren, N.J.
PR Newswire - Thu Sep 01, 10:41AM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, is going to be in Warren, New Jersey, on Wednesday, September 14 at the Wales-Darby New Jersey Office, from 8 a.m. to 6 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Next Stop for Modine Innovation Tour: Islandia, New York
PR Newswire - Wed Aug 31, 10:42AM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, is going to be in Islandia, New York, on Tuesday, September 13 at the Wales-Darby New York Office, from 8 a.m. to 6 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

East Hartford, Connecticut to Host Modine Innovation Tour
PR Newswire - Tue Aug 30, 3:50PM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, will be in East Hartford, Connecticut, on Thursday, September 8 at Cabela's, from 10 a.m. to 4 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Modine Innovation Tour Travels To Greater Boston Area
PR Newswire - Fri Aug 26, 1:25PM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, will be in Randolph, Massachusetts, at Emerson Swan on Thursday, September 1 from 9 a.m. to 4 p.m., and Friday, September 2 from 8:30 a.m. to 1 p.m.; and Woburn, Massachusetts, at F.W. Webb on Wednesday, September 7 from 10 a.m. to 6 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Portsmouth, New Hampshire Next Stop for Modine Innovation Tour
PR Newswire - Fri Aug 26, 12:54PM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, will be in Portsmouth, New Hampshire, on Wednesday, August 31 at Redhook Brewery, from 9 a.m. to 3 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Modine Innovation Tour Headed to Albany, N.Y.
PR Newswire - Wed Aug 24, 1:26PM CDT
Modine Manufacturing Company (NYSE: MOD), a leader in technology in the HVAC industry, is going to be in Saratoga Springs, New York, just north of Albany, on August 29 at the Saratoga Casino Hotel, from 10:30 a.m. to 6 p.m., for their latest stop in the Modine Innovation Tour 2016.
MOD: 11.90 (+0.48)

Modine Reports First Quarter Fiscal 2017 Results
PR Newswire - Tue Aug 02, 4:00PM CDT
Modine Manufacturing Company (NYSE: MOD), a diversified global leader in thermal management technology and solutions, today reported financial results for the first quarter of fiscal year 2017.
MOD: 11.90 (+0.48)

Auto Stocks' Q2 Earnings Slated on Aug 2: CMI, RACE, MOD
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 6:44AM CDT
Let's see what awaits these three auto stocks that are queued up for earnings releases on Aug 2.
CMI: 119.75 (+2.81), MOD: 11.90 (+0.48), RACE: 49.76 (+1.09)

Shares of MOD Up 24.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 23, 1:03AM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 5 months, Modine Manufacturing has returned 24.58% as of today's recent price of $9.73.
MOD: 11.90 (+0.48)

Uptrend Call Working As Modine Manufacturing Stock Rises 23.7% (MOD)
Comtex SmarTrend(R) - Wed Jun 15, 1:41PM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 4 months, Modine Manufacturing has returned 23.69% as of today's recent price of $9.66.
MOD: 11.90 (+0.48)

Modine Manufacturing Shares Up 30.3% Since SmarTrend's Buy Recommendation (MOD)
Comtex SmarTrend(R) - Wed Jun 08, 12:54AM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 4 months, Modine Manufacturing has returned 30.35% as of today's recent price of $10.18.
MOD: 11.90 (+0.48)

Uptrend Call Working As Modine Manufacturing Stock Rises 31.2% (MOD)
Comtex SmarTrend(R) - Tue May 31, 1:20PM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 4 months, Modine Manufacturing has returned 31.24% as of today's recent price of $10.25.
MOD: 11.90 (+0.48)

Modine Reports Fourth Quarter Fiscal 2016 Results
PR Newswire - Wed May 25, 4:05PM CDT
Modine Manufacturing Company (NYSE: MOD), a diversified global leader in thermal management technology and solutions, today reported financial results for the fourth quarter of fiscal year 2016.
MOD: 11.90 (+0.48)

Modine Manufacturing Up 39.2% Since SmarTrend Uptrend Call (MOD)
Comtex SmarTrend(R) - Tue May 24, 12:39AM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 4 months, Modine Manufacturing has returned 39.18% as of today's recent price of $10.87.
MOD: 11.90 (+0.48)

37.8% Return Seen to Date on SmarTrend Modine Manufacturing Call (MOD)
Comtex SmarTrend(R) - Mon May 16, 1:19PM CDT
SmarTrend identified an Uptrend for Modine Manufacturing (NYSE:MOD) on February 4th, 2016 at $7.81. In approximately 3 months, Modine Manufacturing has returned 37.77% as of today's recent price of $10.76.
MOD: 11.90 (+0.48)

Modine to Host Fourth Quarter Fiscal 2016 Earnings Conference Call on May 26, 2016
PR Newswire - Thu May 12, 10:06AM CDT
Modine Manufacturing Company (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that it will host a conference call and webcast to discuss its fourth quarter and full fiscal year financial results for the period ended March 31, 2016, on Thursday, May 26, 2016 at 8:00 a.m. Central Time (9:00 a.m. Eastern Time). Results are scheduled to be released after the market closes on Wednesday, May 25, 2016.
MOD: 11.90 (+0.48)

Modine Selected By Oshkosh Defense To Support Major Military Program
PR Newswire - Mon May 02, 10:40AM CDT
Modine Manufacturing Company (NYSE: MOD) recently won a significant business award from Oshkosh Defense, LLC to produce cooling modules for the company's Joint Light Tactical Vehicle (JLTV) contract, which serves the U.S. Army and Marine Corps. The JLTV production contract calls for Oshkosh to deliver nearly 17,000 vehicles, as well as kits and services over an eight-year period with first vehicle deliveries in October 2016.
MOD: 11.90 (+0.48), OSK: 56.24 (+0.90)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading